Arinobu Fukunaga

Kobe City Medical Center General Hospital

Papers

1

Total Citations

1

H-Index

1

About

Arinobu Fukunaga is a pioneering urologic surgeon whose research focuses on advancing fluorescence-guided surgery for renal cell carcinoma (RCC). His major contribution lies in demonstrating the clinical utility of 5-aminolevulinic acid (5-ALA)-induced protoporphyrin IX (PpIX) fluorescence during robot-assisted partial nephrectomy (RAPN). In his seminal 2025 study, Fukunaga systematically characterized how PpIX fluorescence intensity varies between tumor and normal renal tissues, providing critical evidence that 5-ALA can help surgeons delineate resection margins in real time. This work addresses a persistent challenge in nephron-sparing surgery—ensuring complete tumor removal while preserving healthy parenchyma. With 1 citation to date, this foundational study is poised to influence the integration of photodynamic diagnostics into minimally invasive urologic oncology. Fukunaga’s research bridges the gap between experimental photosensitizers and practical intraoperative imaging, offering a pathway to reduce positive margin rates and improve oncologic outcomes. His achievements highlight the potential of combining established fluorescence agents with robotic platforms, positioning him as a key figure in the evolution of precision surgery for kidney cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Fluorescence by 5-aminolevulinic acid-induced protoporphyrin IX varies in tumor and normal tissues during robot-assisted partial nephrectomy for renal cell carcinoma
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Kobe City Medical Center General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago